Andrx filing accepted by FDA

The FDA accepted for filing an ANDA for ADRX's bioequivalent version of Lodine XL etodolac extended-release tablets to treat osteoarthritis and rheumatoid arthritis. Lodine XL is marketed by Wyeth-Aye...